Facilitating the Recovery of Function Following Stroke: The Efficacy of Inosine

促进中风后功能恢复：肌苷的功效

• 批准号: 8536424
• 负责人: TARA L MOORE
• 金额: $ 19.75万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-01 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8536424
• 关键词: American; Animal Model; Animals; Area; Axon; Blood Vessels; Brain; Brain Injuries; Brain Stem; Cell membrane; Clinical Research; Clinical Trials; Control Groups; Corticospinal Tracts; Data; Development; Dose; Equilibrium; Experimental Designs; FOS Protein; Funding; Future; Goals; Growth; Hand; Hand functions; Harvest; Hour; Human; Immunohistochemistry; Individual; Infarction; Injection of therapeutic agent; Injury; Inosine; Intervention; Ischemia; Ischemic Stroke; Label; Limb structure; MRI Scans; Macaca mulatta; Manganese; Maps; Methods; Modeling; Monkeys; Motor; Motor Cortex; Multiple Sclerosis; Neurodegenerative Disorders; Neurons; Operative Surgical Procedures; Oral; Oral Administration; Parkinson Disease; Patients; Pattern; Performance; Pharmacologic Substance; Play; Postoperative Period; Process; Property; Protein Kinase; Proteins; Purine Nucleosides; Recovery; Recovery of Function; Recurrence; Research; Rodent; Rodent Model; Role; Serum; Signal Pathway; Signal Transduction; Spinal; Spinal Cord; Stroke; Structure; Study models; Testing; Therapeutic; Therapeutic Agents; Therapeutic Intervention; Tracer; Training; Urate; Uric Acid; axon growth; brain tissue; clinically relevant; disability; experience; improved; ischemic lesion; juvenile animal; middle age; motor function recovery; motor impairment; nerve supply; neuroprotection; nonhuman primate; partial recovery; presynaptic; stroke recovery; synaptogenesis

DESCRIPTION (provided by applicant): Approximately 750,000 Americans experience a new or recurrent stroke each year, and 80% of these experience impairment of motor function of the extremities. Partial recovery of motor function occurs even without pharmacological interventions. Clinical studies and animal models suggest that this recovery results from adaptive plasticity and reorganization in intact cortical areas. At the cellular level, reorganizaton following ischemic injury has been found to correlate with dendritic remodeling, increased levels of presynaptic growth- associated proteins and synaptogenesis in peri-infarct regions. Though the precise mechanisms promoting axonal growth and synaptogenesis are unclear, the relationship between these markers of plasticity and recovery provides compelling evidence for investigating plasticity as a target for therapeutic intervention. The therapeutic agent, inosine, stimulates axonal growth and has been shown to enhance functional recovery in rodent models of stroke. Following unilateral stroke, inosine enhances the ability of neurons in the undamaged hemisphere to extend axon collaterals into brainstem and spinal cord areas that have lost normal innervation. This rewiring is accompanied by improved use of an impaired limb. Inosine is a naturally occurring purine nucleoside that crosses the cell membrane and activates Mst3b, a protein kinase that plays a central role in the cell-signaling pathway through which trophic factors stimulate axonal growth. The plasticity enhancing properties of inosine are currently being tested clinically in patients with multiple sclerosis and Parkinson's Disease (Parkinson's Disease Study Group, 2011; Markowitz et al, 2009). The goal of this proposal is to use our rhesus monkey model of cortical ischemic stroke developed with R21 AG-028680 to explore the efficacy of inosine in the recovery of motor function following cortical ischemia in a gyrencephalic animal with brain structure and fine motor dexterity highly similar to humans. !

描述（由申请人提供）：每年大约有 750,000 名美国人经历新发或复发性中风，其中 80% 的人患有四肢运动功能障碍。即使没有药物干预，运动功能也会部分恢复。临床研究和动物模型表明，这种恢复是完整皮质区域的适应性可塑性和重组的结果。在细胞水平上，已发现缺血性损伤后的重组与树突重塑、突触前生长相关蛋白水平增加以及梗死周围区域的突触发生相关。尽管促进轴突生长和突触发生的确切机制尚不清楚，但这些可塑性和恢复标志物之间的关系为研究可塑性作为治疗干预的目标提供了令人信服的证据。治疗剂肌苷可刺激轴突生长，并已被证明可以增强中风啮齿动物模型的功能恢复。单侧中风后，肌苷增强未受损半球神经元将轴突侧支延伸至失去正常神经支配的脑干和脊髓区域的能力。这种重新布线伴随着受损肢体的使用得到改善。肌苷是一种天然存在的嘌呤核苷，可穿过细胞膜并激活 Mst3b，Mst3b 是一种蛋白激酶，在细胞信号传导途径中发挥核心作用，营养因子通过该途径刺激轴突生长。目前，肌苷增强可塑性的特性正在多发性硬化症和帕金森病患者身上进行临床测试（帕金森病研究组，2011；Markowitz 等，2009）。本提案的目标是利用我们用 R21 AG-028680 开发的皮质缺血性中风恒河猴模型来探索肌苷在大脑结构和精细运动灵活性高度相似的脑回动物皮质缺血后运动功能恢复中的功效对人类。 ！

项目成果

Cell based therapy reduces secondary damage and increases extent of microglial activation following cortical injury.

基于细胞的治疗减少了继发性损伤并增加了皮质损伤后小胶质细胞的活化程度。

• 发表时间: 2019-08-15
• 影响因子: 2.9
• 作者: Orczykowski, Mary E;Calderazzo, Samantha M;Shobin, Eli;Pessina, Monica A;Oblak, Adrian L;Finklestein, Seth P;Kramer, Brian C;Mortazavi, Farzad;Rosene, Douglas L;Moore, Tara L
• 通讯作者: Moore, Tara L

Inflammation and Stem Cell Therapy for Stroke

炎症和中风干细胞疗法

• DOI: 10.1007/s10734-017-0118-0
• 发表时间: 2024-09-13
• 期刊: Higher Education
• 影响因子: 5
• 作者: Ruimin Ge